Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Moleculin Biotech, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −7 vs. Q2 2021
- Shares held
- 2.86M
- −122.2K (−4.1%) vs. Q2 2021
- Total value
- $8.57M
- −$2.36M (−21.6%) vs. Q2 2021
- New holders
- 2
- 5 more added
- Sold out
- 9
- 8 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $518.5K |
| Q1 2026 | 20 | $347.9K |
| Q4 2025 | 17 | $315.2K |
| Q3 2025 | 25 | $412.7K |
| Q2 2025 | 22 | $117.9K |
| Q1 2025 | 23 | $1.44M |
| Q4 2024 | 21 | $790.0K |
| Q3 2024 | 19 | $1.31M |
| Q2 2024 | 16 | $1.10M |
| Q1 2024 | 19 | $1.53M |
| Q4 2023 | 24 | $4.44M |
| Q3 2023 | 22 | $925.1K |
| Q2 2023 | 22 | $1.33M |
| Q1 2023 | 23 | $2.91M |
| Q4 2022 | 25 | $3.17M |
| Q3 2022 | 27 | $3.16M |
| Q2 2022 | 26 | $4.32M |
| Q1 2022 | 23 | $5.26M |
| Q4 2021 | 26 | $5.61M |
| Q3 2021 | 24 | $8.57M |
| Q2 2021 | 32 | $10.9M |
| Q1 2021 | 29 | $8.74M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Moleculin Biotech, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tower Research Capital LLC (TRC) | 40 | $0 | 0.00% | −2,473−98.4% | Reduced |
| Wells Fargo & Company | 175 | $1.00K | 0.00% | +5+2.9% | Added |
| North Star Investment Management Corp. | 250 | $1.00K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 334 | $1.00K | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 221 | $1.00K | 0.00% | 00.0% | Unchanged |
| Prestige Wealth Management Group LLC | 167 | $1.00K | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 334 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 801 | $2.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,403 | $4.00K | 0.00% | +332+31.0% | Added |
| Migdal Insurance & Financial Holdings Ltd. | 2,284 | $7.00K | 0.00% | +2,284 | New |
| Rockefeller Capital Management L.P. | 2,777 | $8.00K | 0.00% | −192−6.5% | Reduced |
| Morgan Stanley | 6,000 | $18.0K | 0.00% | −3,713−38.2% | Reduced |
| Bank of America Corp | 6,650 | $20.0K | 0.00% | −12−0.2% | Reduced |
| Raymond James & Associates | 14,175 | $43.0K | 0.00% | −811−5.4% | Reduced |
| Charles Schwab Investment Management Inc | 20,198 | $61.0K | 0.00% | +20,198 | New |
| Occudo Quantitative Strategies LP | 23,484 | $70.0K | 0.01% | −5,704−19.5% | Reduced |
| Susquehanna Fundamental Investments, LLC | 27,400 | $82.0K | 0.00% | −3,800−12.2% | Reduced |
| Truist Financial Corp | 29,167 | $88.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 50,731 | $152.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 59,900 | $180.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 245,612 | $736.0K | 0.00% | +8,026+3.4% | Added |
| BlackRock Inc. | 270,402 | $812.0K | 0.00% | −6,844−2.5% | Reduced |
| Sio Capital Management, LLC | 1,040,529 | $3.12M | 1.01% | +35,684+3.6% | Added |
| Vanguard Group Inc | 1,053,062 | $3.16M | 0.00% | +5,533+0.5% | Added |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −38,053−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −32,997−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −31,120−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −25,707−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,302−100.0% | Sold out |
| Taylor, Cottrill, Erickson & Associates, Inc. | 0 | $0 | 0.00% | −16,964−100.0% | Sold out |
| CVA Family Office, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Salem Investment Counselors Inc | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Strategic Blueprint, LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |